Latest Vaccinogen Inc. (VGEN) Headlines Vaccinoge
Post# of 4
Posted On: 03/12/2014 12:47:04 AM
Latest Vaccinogen Inc. (VGEN) Headlines
Vaccinogen Names Dr. Benjamin Carson and Dr. Jan B. Vermorken to Medical Advisory Board
PR Newswire - Thu Oct 24, 6:00AM CDT
Vaccinogen, Inc., (OTC.QB: VGEN) a cancer vaccine company, today announced that noted pediatric neurosurgeon Benjamin S. Carson, M.D. and prominent oncologist Jan B. Vermorken, M.D., Ph.D. have joined the company's medical advisory board.
Vaccinogen CEO to Present as a Keynote Speaker at the Immunology Summit-2013
GlobeNewswire - Fri Oct 11, 10:08AM CDT
Vaccinogen, Inc. (OTC:VGEN) a pioneer in cancer immunotherapy, today announced that its cofounder, Chairman, and CEO Michael G. Hanna, Jr., Ph.D., will deliver a keynote address on the impact of genomic sequencing data in cancer immunotherapy at the 2nd International Conference on Clinical & Cellular Immunology (the Immunology Summit-2013) on October 15, 2013. The conference runs from October 15 to 17 in Las Vegas.
Vaccinogen Names Dr. Benjamin Carson and Dr. Jan B. Vermorken to Medical Advisory Board
PR Newswire - Thu Oct 24, 6:00AM CDT
Vaccinogen, Inc., (OTC.QB: VGEN) a cancer vaccine company, today announced that noted pediatric neurosurgeon Benjamin S. Carson, M.D. and prominent oncologist Jan B. Vermorken, M.D., Ph.D. have joined the company's medical advisory board.
Vaccinogen CEO to Present as a Keynote Speaker at the Immunology Summit-2013
GlobeNewswire - Fri Oct 11, 10:08AM CDT
Vaccinogen, Inc. (OTC:VGEN) a pioneer in cancer immunotherapy, today announced that its cofounder, Chairman, and CEO Michael G. Hanna, Jr., Ph.D., will deliver a keynote address on the impact of genomic sequencing data in cancer immunotherapy at the 2nd International Conference on Clinical & Cellular Immunology (the Immunology Summit-2013) on October 15, 2013. The conference runs from October 15 to 17 in Las Vegas.
(0)
(0)